doi: 10.1111/j.1749-6632.1972.tb16334.x.
Hemorrhagic disease associated with inhibitors of fibrin cross-linkage
- PMID: 4508924
- DOI: 10.1111/j.1749-6632.1972.tb16334.x
Item in Clipboard
Hemorrhagic disease associated with inhibitors of fibrin cross-linkage
Ann N Y Acad Sci.
.
No abstract available
Similar articles
-
Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).Br J Haematol. 1972 Jul;23(1):17-27. doi: 10.1111/j.1365-2141.1972.tb03455.x. Br J Haematol. 1972. PMID: 5045959 No abstract available.
-
Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.Ann N Y Acad Sci. 1972 Dec 8;202:6-30. doi: 10.1111/j.1749-6632.1972.tb16319.x. Ann N Y Acad Sci. 1972. PMID: 4565370 Review. No abstract available.
-
Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.Biochemistry. 1991 Oct 22;30(42):10164-70. doi: 10.1021/bi00106a013. Biochemistry. 1991. PMID: 1681898
-
An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.Blood. 1974 Dec;44(6):771-81. Blood. 1974. PMID: 4214572 No abstract available.
-
Acquired plasma factor XIII deficiencies.Haematologica. 1993 Nov-Dec;78(6 Suppl 2):5-10. Haematologica. 1993. PMID: 8039759 Review.
Cited by
-
Immunologically generated circulating anticoagulants in humans.Surv Immunol Res. 1984;3(1):64-9. doi: 10.1007/BF02918599. Surv Immunol Res. 1984. PMID: 6426006 Review. No abstract available.
-
The human fibrin-stabilizing factors.Mol Cell Biochem. 1978 Jun 28;20(2):67-75. doi: 10.1007/BF00241384. Mol Cell Biochem. 1978. PMID: 353534 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
